- Home
- SBFM vs FTAIM Comparison
SBFM vs FTAIM Comparison
Compare SBFM & FTAIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- FTAIM
- Stock Information
- Founded
- SBFM 2006
- FTAIM N/A
- Country
- SBFM United States
- FTAIM United States
- Employees
- SBFM N/A
- FTAIM 580
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- FTAIM Misc Corporate Leasing Services
- Sector
- SBFM Health Care
- FTAIM Industrials
- Exchange
- SBFM Nasdaq
- FTAIM Nasdaq
- Market Cap
- SBFM 4.9M
- FTAIM N/A
- IPO Year
- SBFM N/A
- FTAIM N/A
- Fundamental
- Price
- SBFM $1.51
- FTAIM $25.65
- Analyst Decision
- SBFM Strong Buy
- FTAIM
- Analyst Count
- SBFM 1
- FTAIM 0
- Target Price
- SBFM $15.00
- FTAIM N/A
- AVG Volume (30 Days)
- SBFM 4.3M
- FTAIM N/A
- Earning Date
- SBFM 05-19-2025
- FTAIM N/A
- Dividend Yield
- SBFM N/A
- FTAIM N/A
- EPS Growth
- SBFM N/A
- FTAIM N/A
- EPS
- SBFM N/A
- FTAIM N/A
- Revenue
- SBFM $34,874,283.00
- FTAIM N/A
- Revenue This Year
- SBFM $192.48
- FTAIM N/A
- Revenue Next Year
- SBFM N/A
- FTAIM N/A
- P/E Ratio
- SBFM N/A
- FTAIM N/A
- Revenue Growth
- SBFM 44.75
- FTAIM N/A
- 52 Week Low
- SBFM $1.17
- FTAIM N/A
- 52 Week High
- SBFM $33.60
- FTAIM N/A
- Technical
- Relative Strength Index (RSI)
- SBFM 43.22
- FTAIM 48.76
- Support Level
- SBFM $1.17
- FTAIM $25.45
- Resistance Level
- SBFM $1.59
- FTAIM $25.74
- Average True Range (ATR)
- SBFM 0.17
- FTAIM 0.37
- MACD
- SBFM 0.04
- FTAIM 0.05
- Stochastic Oscillator
- SBFM 70.89
- FTAIM 76.61
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About FTAIM FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares
FTAI Aviation Ltd is a aerospace company .It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.